Hedia Appoints Rasmus Kofoed as New CEO
Danish diabetes-tech company Hedia has appointed Rasmus Kofoed as its new Chief Executive Officer, effective December 1, 2025, announced in a press release. Kofoed succeeds Lars Christian Lund, who is leaving after two years to take up a Group CEO position at another international company.
Hedia develops digital tools that help people with insulin-dependent diabetes manage their treatment using data, artificial intelligence, and app-based technology. Founded in 2016, the company has grown into a leading European player in digital diabetes management.
Kofoed brings extensive experience from leadership roles at Novo Nordisk, Abbott, Roche, and Medtronic, and previously served as CEO of ChemoMetec. As Hedia’s new CEO, he aims to strengthen the company’s product platform and expand its international partnerships.
Chairman Carl Bilbo said the transition marks Hedia’s next phase of growth, building on the company’s regulatory and commercial progress under Lund’s leadership.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 17 Masimo Gets FDA Clearance for AFib Detection on Radius VSM Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflowsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Heidi Raises $340 Million for Health Care AI Expansion
Prologue Medicines names Stephen Harrison chief scientific officer
Briya appoints Jason Hein as chief commercial officer
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
atNorth Executive Fredrik Jansson Moves to Senior Advisor Role
Daily AI Brief: the AI news that matters, in your inbox.